Group-Based Exercise in CKD Stage 3b to 4: A Randomized Clinical TrialPlain-Language Summary

• Published in: Kidney medicine Vol. 3; no. 6; pp. 951 - 961.e1
• Main Authors: Shuchi Anand, Susan L. Ziolkowski, Ahad Bootwala, Jianheng Li, Nhat Pham, Jason Cobb, Felipe Lobelo
• Format: Journal Article
• Language: English
• Published: Elsevier 01.11.2021
• Subjects: Chronic kidney disease; exercise physical activity; mobile health; underserved populations
• ISSN: 2590-0595; 2590-0595

Rationale & Objective: We aimed to test interventions to improve physical activity in persons with advanced chronic kidney disease not yet receiving dialysis. Study Design: Randomized controlled trial with parallel-group design. Setting & Participants: We embedded a pragmatic referral to exercise programming in high-volume kidney clinics servicing diverse populations in San Jose, CA, and Atlanta, GA. We recruited 56 participants with estimated glomerular filtration rates < 45 mL/min/1.73 m2. Interventions: We randomly assigned participants to a mobile health (mHealth) group—wearable activity trackers and fitness professional counseling, or an Exercise is Medicine intervention framework (EIM) group—mHealth components plus twice-weekly small-group directed exercise sessions customized to persons with kidney disease. We performed assessments at baseline, 8 weeks at the end of active intervention, and 16 weeks after passive follow-up and used multilevel mixed models to assess between-group differences. Outcomes: Activity tracker total daily step count. Results: Of 56 participants, 86% belonged to a racial/ethnic minority group; randomly assigned groups were well balanced on baseline step count. In intention-to-treat analyses, the EIM and mHealth groups both experienced declines in daily step counts, but there was an attenuated reduction in light intensity physical activity (standard error 0.2 [5.8] vs −8.5 [5.4] min/d; P = 0.08) in the EIM compared with the mHealth group at 8 weeks. In as-treated analyses, total daily step count, distance covered, and light and moderate-vigorous activity minutes per day improved in the EIM group and declined in the mHealth group at 8 weeks (standard error +335 [506] vs −884 [340] steps per day; P = 0.05; P < 0.05 for secondary measures), but group differences faded at 16 weeks. There were no differences in quality-of-life and mental health measures during the study. Limitations: Small sample size, limited duration of study, assessment of intermediate outcomes (steps per day). Conclusions: A clinic-integrated referral to small-group exercise sessions is feasible, safe, and moderately effective in improving physical activity in an underserved population with high comorbid conditions. Funding: Normon S Coplon Applied Pragmatic Clinical Research program. Trial Registration: NCT03311763